Scheen, André J.
Article History
First Online: 5 February 2018
Compliance with Ethical Standards
:
: No sources of funding were used to assist in the preparation of this manuscript. No conflicts of interest are directly relevant to the content of this manuscript.A.J. Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck Sharp & Dohme, NovoNordisk, Sanofi, and Servier.
: This article does not contain any studies with human or animal subjects performed by the author.